XML 39 R10.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Activities      
Net Income (Loss) $ (1,023,528) $ 12,295,179 $ 5,117,598
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:      
Equity-Based and Other Non-Cash Compensation 730,236 529,816 326,758
Change in Unrealized (Gains) Losses - Asset Management 2,964,043 (5,338,714) (3,479,865)
Net Accretion and Amortization 364,162 386,867 (64,154)
Other Non-Cash Amounts 77,780 (102,871) 10,901
Cash Flows Due to Changes in Operating Assets and Liabilities:      
Change in Consolidation (66,593) (373,761) 8,624
Change in Due from / to Affiliates (459,226) (431,292) (214,227)
Change in Other Assets 874,463 465,288 (571,336)
Change in Accrued Expenses and Other Liabilities (3,122,805) 2,143,039 1,187,516
Net Cash Provided (Used) by Operating Activities (5,279,259) (7,176,708) (5,953,693)
Investing Activities      
Purchases of Fixed Assets (85,056) (102,049) (142,258)
Development of Oil and Natural Gas Properties 0 0 (11,128)
Net Cash Provided (Used) by Investing Activities (13,647,272) (9,605,548) (153,386)
Financing Activities      
Common Stock Dividends (444,341) (331,429) (297,324)
Distributions to Redeemable Noncontrolling Interests (2,540) (2,015) 0
Contributions from Redeemable Noncontrolling Interests 69,322 0 0
Distributions to Noncontrolling Interests (7,039,914) (7,484,620) (5,160,539)
Contributions from Noncontrolling Interests 13,622,035 13,847,646 9,242,255
Issuance of Series C Mandatory Convertible Preferred Stock (net of issuance costs) 0 0 1,115,792
Redemption of Series A and B Preferred Stock 0 (500,000) 0
Net Delivery of Common Stock (Equity Incentive Plans) (65,717) (166,844) (78,317)
Repurchases of Common Stock (346,651) (269,710) (246,160)
Private Placement Share Issuance 0 38,463 0
Proceeds from Debt Obligations 20,439,101 30,369,415 16,620,416
Repayment of Debt Obligations (13,910,767) (21,473,835) (11,293,648)
Financing Costs Paid (33,276) (128,753) (42,216)
Net Cash Provided (Used) by Financing Activities 22,055,366 20,363,994 9,803,704
Effect of exchange rate changes on cash, cash equivalents and restricted cash (269,769) (48,891) 59,416
Net Increase/(Decrease) in Cash, Cash Equivalents and Restricted Cash 2,859,066 3,532,847 3,756,041
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 10,526,304 6,993,457 3,237,416
Cash, Cash Equivalents and Restricted Cash, End of Period 13,385,370 10,526,304 6,993,457
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]      
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 13,385,370 10,526,304 6,993,457
Supplemental Disclosures of Cash Flow Information      
Payments for Interest 1,500,123 1,241,886 1,045,297
Payments for Income Taxes 764,966 658,578 179,915
Payments for Operating Lease Liabilities 52,184 46,585 54,056
Supplemental Disclosures of Non-Cash Investing and Financing Activities      
Equity-Based and Other Non-Cash Contributions 578,492 434,278 327,134
Non-Cash Contribution from Noncontrolling Interests 84,786 845,943 618,452
Non-Cash Distribution to Redeemable Noncontrolling Interests 0 (11,399) 0
Debt Obligations - Net Gains (Losses), Translation and Other 2,022,751 593,699 (849,179)
Holdings Merger 6,959,322 0 0
Tax Effects - Exchange of KKR Holdings L.P. Units and Other (1,064,869) 6,929 (9,167)
Transfer of Oil and Natural Gas Properties 0 0 (69,027)
Right-of-Use Assets obtained in Exchange for new Operating Lease Liabilities 159,367 46,284 79,116
Investments Acquired through Reinsurance Agreements 5,552,508 16,339,358 0
Policyholder Liabilities and Accruals Acquired through Reinsurance Agreements 1,547,572 4,070,473 0
Contractholder Deposit Funds Acquired through Reinsurance Agreements 5,542,192 14,773,306 0
Change in Consolidation      
Investments (57,440) (5,293,537) 3,480
Due From Affiliates 0 (3,735) 0
Other Assets (59,675) (67,255) 46,892
Debt Obligations (50,339) (4,502,453) 259,822
Due to Affiliates (174) (517) 0
Accrued Expenses and Other Liabilities (4,162) (39,428) 32,494
Noncontrolling Interests 0 (1,132,796) (239,258)
Global Atlantic      
Investing Activities      
Acquisitions, net of cash acquired 0 (473,779) 0
KJR Management      
Investing Activities      
Acquisitions, net of cash acquired (1,690,702) 0 0
Asset Management      
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:      
Net Realized (Gains) Losses - Asset Management (1,298,506) (2,382,209) (162,939)
Change in Unrealized (Gains) Losses - Asset Management 2,964,043 (5,338,714) (3,479,865)
Capital Allocation-Based (Income) Loss - Asset Management 2,500,509 (6,842,414) (2,224,100)
Cash Flows Due to Changes in Operating Assets and Liabilities:      
Investments Purchased - Asset Management (38,934,027) (73,509,382) (47,577,486)
Proceeds from Investments - Asset Management 28,508,937 62,902,614 41,689,017
Financing Activities      
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 6,833,966 6,993,457 3,237,416
Cash, Cash Equivalents and Restricted Cash, End of Period 6,958,756 6,833,966 6,993,457
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]      
Cash and Cash Equivalents 6,705,325 6,699,668 6,507,874
Restricted Cash and Cash Equivalents 253,431 134,298 485,583
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 6,958,756 6,833,966 6,993,457
Insurance      
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:      
Net Investment-Related (Gains) Losses - Insurance 1,035,879 860,165 0
Interest Credited to Policyholder Account Balances (net of Policy Fees) - Insurance 1,245,467 1,740,965 0
Cash Flows Due to Changes in Operating Assets and Liabilities:      
Reinsurance Transactions and Acquisitions, Net of Cash Provided - Insurance 1,282,677 1,373,597 0
Change in Premiums, Notes Receivable and Reinsurance Recoverable, Net of Reinsurance Premiums Payable - Insurance 685,487 685,802 0
Change in Deferred Policy Acquisition Costs - Insurance (483,449) (412,671) 0
Change in Policy Liabilities and Accruals, Net - Insurance (160,765) (1,166,726) 0
Investing Activities      
Investments Purchased - Insurance (47,191,313) (58,617,575) 0
Proceeds from Investments - Insurance 35,356,268 49,567,361 0
Other Investing Activities, Net - Insurance (36,469) 20,494 0
Financing Activities      
Additions to Contractholder Deposit Funds - Insurance 22,592,703 14,720,510 0
Withdrawals from Contractholder Deposit Funds - Insurance (13,315,401) (8,777,045) 0
Reinsurance Transactions, Net of Cash Provided - Insurance 69,596 610,314 0
Other Financing Activity, Net - Insurance 490,216 98 0
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 3,692,338 0 0
Cash, Cash Equivalents and Restricted Cash, End of Period 6,426,614 3,692,338 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]      
Cash and Cash Equivalents 6,118,231 3,391,934 0
Restricted Cash and Cash Equivalents 308,383 300,404 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 6,426,614 3,692,338 0
Series A And Series B Preferred Stock      
Financing Activities      
Preferred Stock Dividends 0 (19,201) (33,364)
Series C Mandatory Convertible Preferred Stock Dividends      
Financing Activities      
Preferred Stock Dividends $ (69,000) $ (69,000) $ (23,191)